Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)

Active, not recruitingOBSERVATIONAL
Enrollment

1,003

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Coronary Microvascular DiseaseCoronary Artery DiseaseIschemic Heart Disease
Interventions
DIAGNOSTIC_TEST

Invasive physiologic assessment

"All coronary physiologic parameters are measured following diagnostic angiography. Resting pd/pa, FFR, CFR and IMR will be calculated using coronary physiologic parameters.~In patients treated by PCI, post-PCI physiologic assessment including CFR, IMR, and FFR will be performed."

DIAGNOSTIC_TEST

Intravascular imaging

By the operator's discretion, stent-optimization will be performed under intravascular imaging devices (IVUS \[Boston Scientific, Natick, Massachusetts, USA\] or OCT \[Abbott Vascular\], St. Paul, MN, USA\]).

Trial Locations (7)

Unknown

Chonnam National University Hospital, Gwangju

Chosun University Hospital, Gwangju

Gyeongsang National University Hospital, Jinju

Seoul National University Bundang Hospital, Seongnam

Samsung Medical Center, Seoul

Seoul National University Boramae Medical Center, Seoul

Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
collaborator

Chonnam National University Hospital

OTHER

collaborator

Chosun University Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Seoul St. Mary's Hospital

OTHER

lead

Samsung Medical Center

OTHER

NCT05369182 - Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry) | Biotech Hunter | Biotech Hunter